News Feed

A large study involving more than 21,000 people with glaucoma suggests that genetic information could help identify those at high risk long before symptoms appear. Researchers used a polygenic risk score, which combines the effects of many genetic variants, to estimate each person's lifetime risk. Nearly half of those in the highest-risk group developed glaucoma, compared with fewer than 3% in the lowest-risk group. People with higher genetic risk also tended to develop more severe disease requiring additional medications, laser therapy, or surgery. While further research is needed, these findings could pave the way for personalized screening and earlier treatment to help prevent irreversible vision loss.

A large study using data from the UK Biobank suggests that higher blood glucose levels may accelerate brain aging. Researchers combined MRI brain scans, blood metabolomics, genetics, and artificial intelligence to identify factors linked to an "older-looking" brain. Among nine significant blood metabolites, glucose showed the strongest association with accelerated brain aging. Higher glucose levels were also linked to an increased risk of dementia, Alzheimer's disease, Parkinson's disease, stroke, depression, and poorer cognitive performance. While the findings do not prove cause and effect in humans, they highlight blood sugar control as a potentially modifiable factor that could help protect brain health and reduce the risk of age-related neurological disorders.

Researchers have developed an innovative biodegradable scaffold that restored normal skull growth in mouse models of craniosynostosis, a birth defect in which skull bones fuse too early. Unlike current surgeries that often lead to re-fusion, the new "bone-suture-bone" scaffold recreates the natural stem cell environment needed for healthy skull development. In the study, the implant prevented abnormal bone fusion, maintained skeletal stem cells, and significantly improved craniofacial growth. Although the research is still in animals, the findings offer hope for regenerative therapies that could treat the root cause of craniosynostosis and potentially improve outcomes for children with this condition.

A large review of 28 studies suggests that people with allergic diseases may have a slightly higher overall risk of developing cancer, though the increase is small. Researchers found the strongest association in people with asthma, while hay fever and atopic dermatitis showed no significant link. The relationship also varied by region and cancer type, with some cancers showing increased risk and others showing the opposite trend. Importantly, the findings do not prove that allergies cause cancer. Experts say more research is needed to understand the biological connection and identify which groups, if any, may face a meaningful increase in risk.

A new study has identified a previously overlooked mechanism that may explain how brain cells die in Alzheimer’s disease and frontotemporal dementia. Researchers believe this newly discovered pathway plays a major role in the progressive loss of neurons that drives memory decline and cognitive impairment. The discovery opens the door to developing treatments that target this cell-death process before irreversible damage occurs. Instead of only addressing symptoms, future therapies could potentially slow disease progression by protecting vulnerable brain cells. While more research and clinical testing are needed, these findings offer fresh hope for more effective treatments against devastating neurodegenerative diseases.

Researchers have uncovered how mutations in the ATRX gene help aggressive gliomas grow by reshaping the way DNA is folded and organized inside cancer cells. This altered DNA structure switches on genes that promote tumor growth, spread, and survival. In laboratory and animal studies, blocking one of these pathways - particularly the HOXA gene family—slowed tumor growth, triggered cancer cell death, and improved survival. The findings suggest that targeting the downstream effects of ATRX mutations, rather than the mutation itself, could offer a more precise treatment strategy. Although further clinical studies are needed, this discovery opens new possibilities for personalized therapies against hard-to-treat brain cancers.

A new study suggests that forcing treatment-resistant breast cancer cells to die through a process called necroptosis could do more than eliminate tumor cells - it may also boost the body's immune response. Using patient-derived 3D mini-tumors (organoids), researchers found that necroptosis caused cancer cells to release danger signals that activated immune pathways, including those involving natural killer (NK) cells, which help destroy tumors. Unlike apoptosis, a "silent" form of cell death, necroptosis alerts the immune system, potentially strengthening anti-cancer defenses. These findings highlight a promising strategy for future cancer therapies while showcasing organoids as powerful models for studying disease and testing new treatments.

Scientists are making progress toward blood-based biomarkers that could improve Parkinson’s disease research. A key focus is alpha-synuclein, a protein that forms harmful clumps in the brains of people with Parkinson’s. Researchers are studying both total alpha-synuclein and its disease-linked form, pS129-alpha-synuclein, which may better reflect disease activity. Unlike spinal fluid tests, blood tests are less invasive and could allow easier monitoring over time, helping researchers track disease progression and evaluate new therapies. While technical challenges remain, advances in ultra-sensitive detection methods are bringing researchers closer to reliable, scalable biomarkers that could accelerate future Parkinson’s diagnosis and treatment research.

A new animal study suggests that obstructive sleep apnea (OSA) may worsen idiopathic pulmonary fibrosis (IPF), a serious disease that causes progressive lung scarring. Researchers found that intermittent drops in oxygen levels—similar to those experienced during sleep apnea—intensified lung damage, collagen buildup, and fibrosis, especially when oxygen deprivation occurred before lung injury. These findings indicate that sleep apnea may accelerate the progression of IPF rather than simply coexist with it. The study also highlights the importance of early diagnosis and treatment of sleep apnea, which could help slow lung scarring and improve long-term outcomes for people living with IPF.

Most people focus on cutting salt, but getting enough potassium is just as important. Surprisingly, around 86% of people worldwide consume less potassium than the recommended amount. This essential mineral supports healthy nerves, muscles, heart rhythm, blood pressure, and kidney function. Diets rich in processed foods are often high in sodium but low in potassium, increasing the risk of high blood pressure, stroke, and heart disease. The good news? Eating more potassium-rich foods such as bananas, spinach, sweet potatoes, beans, yogurt, and avocados can help restore a healthier balance. Small dietary changes today can make a big difference to your long-term health.